Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

<p><strong> Background</strong></p> Dexamethasone and remdesivir have the potential to reduce coronavirus disease 2019 (COVID)–related mortality or recovery time, but their cost-effectiveness in countries with limited intensive care resources is unknown. <p><strong&...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Jo, Y, Jamieson, L, Edoka, I, Long, L, Silal, S, Pulliam, JRC, Moultrie, H, Sanne, I, Meyer-Rath, G, Nichols, BE
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Oxford University Press 2021

Míreanna comhchosúla

The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing intensive care unit capacity
de réir: Nichols, BE, et al.
Foilsithe / Cruthaithe: (2020)

The National COVID-19 Epi Model (NCEM): estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa
de réir: Silal, SP, et al.
Foilsithe / Cruthaithe: (2023)

The role of modelling and analytics in South African COVID-19 planning and budgeting
de réir: Meyer-Rath, G, et al.
Foilsithe / Cruthaithe: (2023)

Differential in-hospital mortality and intensive care treatment over time: informing hospital pathways for modelling COVID-19 in South Africa
de réir: Jamieson, L, et al.
Foilsithe / Cruthaithe: (2023)

Inpatient Care Costs of COVID-19 in South Africa’s Public Healthcare System
de réir: Ijeoma Edoka, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Differential in-hospital mortality and intensive care treatment over time: Informing hospital pathways for modelling COVID-19 in South Africa.
de réir: Lise Jamieson, et al.
Foilsithe / Cruthaithe: (2023-01-01)

The role of modelling and analytics in South African COVID-19 planning and budgeting.
de réir: Gesine Meyer-Rath, et al.
Foilsithe / Cruthaithe: (2023-01-01)

The role of modelling and analytics in South African COVID-19 planning and budgeting
de réir: Gesine Meyer-Rath, et al.
Foilsithe / Cruthaithe: (2023-01-01)

The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa
de réir: Sheetal Prakash Silal, et al.
Foilsithe / Cruthaithe: (2023-01-01)

The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa.
de réir: Sheetal Prakash Silal, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa
de réir: Silal, SP, et al.
Foilsithe / Cruthaithe: (2022)

Dexamethasone and remdesivir: finding method in the COVID-19 madness
de réir: Pauline Vetter, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study
de réir: Andrea Carta, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Cancer mortality trends in South Africa: 1997 - 2016
de réir: M L Nhleko, et al.
Foilsithe / Cruthaithe: (2023-08-01)

A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19
de réir: Dallis Q. Ngo, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Pancreatic cancer mortality in South Africa: A case-control study
de réir: M L Nhleko, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Cancer mortality distribution in South Africa, 1997–2016
de réir: Mandlakayise Lucky Nhleko, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Costs of the COVID-19 vaccination programme: estimates from the West Rand district of South Africa, 2021/2022
de réir: Ijeoma Edoka, et al.
Foilsithe / Cruthaithe: (2024-07-01)

The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis
de réir: Gesine Meyer-Rath, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients
de réir: Kaiyan Liu, et al.
Foilsithe / Cruthaithe: (2023-03-01)

UPLC-PDA factorial design assisted method for simultaneous determination of oseltamivir, dexamethasone, and remdesivir in human plasma
de réir: Hanan I. EL-Shorbagy, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Prognostic factors for poor outcomes in patients with severe COVID-19 treated with remdesivir plus dexamethasone in Taiwan
de réir: Yi-Hsuan Lai, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Integrated multi‐month dispensing for HIV and hypertension in South Africa: A model of epidemiological impact and cost‐effectiveness
de réir: Youngji Jo, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Cost and outcomes of routine HIV care and treatment: public and private service delivery models covering low-income earners in South Africa
de réir: L. C. Long, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Modelling the Cost-Effectiveness of Hepatitis A in South Africa
de réir: Jenna Patterson, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Death trends for 2010 - 2022 for members of a large private medical scheme in South Africa
de réir: L Steenkamp, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data
de réir: Mariet Benade, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data.
de réir: Mariet Benade, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Simultaneous HPLC determination of remdesivir and dexamethasone in the presence of metformin, sitagliptin, and glimepiride in a synthetic mixture and spiked human plasma
de réir: Stanislav Bozhanov, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial
de réir: Abu Taiub Mohammed Mohiuddin Chowdhury, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Healthcare costs of paternal depression in the postnatal period.
de réir: Edoka, I, et al.
Foilsithe / Cruthaithe: (2011)

Healthcare costs of paternal depression in the postnatal period
de réir: Edoka, I, et al.
Foilsithe / Cruthaithe: (2011)

Towards malaria elimination in Mpumalanga, South Africa: a population-level mathematical modelling approach.
de réir: Silal, S, et al.
Foilsithe / Cruthaithe: (2014)

The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa – a systematic literature review
de réir: Sithabiso D. Masuku, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Attrition through multiple stages of pre-treatment and ART HIV care in South Africa.
de réir: Matthew P Fox, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Clinical outcomes of remdesivir-treated COVID-19 patients in South Korea
de réir: Mi Yu, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Exploring the seasonality of reported treated malaria cases in Mpumalanga, South Africa.
de réir: Sheetal Prakash Silal, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
de réir: Calvin Chiu, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact
de réir: Guillaume Béraud, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.
de réir: Guillaume Béraud, et al.
Foilsithe / Cruthaithe: (2022-01-01)